Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.45 HKD | +0.20% | -1.10% | +38.90% |
May. 27 | Giant Biogene Places 33.2 Million Shares for About HK$1.63 | MT |
Apr. 30 | Giant Biogene’s Profit Up 47% in 2023 | MT |
Sales 2024 * | 4.69B 648M 5.06B | Sales 2025 * | 6.02B 831M 6.5B | Capitalization | 46.22B 6.38B 49.9B |
---|---|---|---|---|---|
Net income 2024 * | 1.79B 248M 1.94B | Net income 2025 * | 2.27B 314M 2.45B | EV / Sales 2024 * | 9 x |
Net cash position 2024 * | 4.03B 557M 4.36B | Net cash position 2025 * | 5.5B 760M 5.94B | EV / Sales 2025 * | 6.76 x |
P/E ratio 2024 * |
25.5
x | P/E ratio 2025 * |
20.1
x | Employees | 1,164 |
Yield 2024 * |
1.36% | Yield 2025 * |
1.75% | Free-Float | 47.45% |
1 day | +0.20% | ||
1 week | -1.10% | ||
1 month | +3.13% | ||
3 months | +38.52% | ||
6 months | +38.71% | ||
Current year | +38.90% |
Managers | Title | Age | Since |
---|---|---|---|
Jian Ya Yan
CEO | Chief Executive Officer | 57 | 00-04-30 |
Hui Juan Zhang
DFI | Director of Finance/CFO | 37 | - |
Yu Bo Yan
BRD | Director/Board Member | 28 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sze Wing Wong
BRD | Director/Board Member | 46 | 22-04-20 |
Jian Ya Yan
CEO | Chief Executive Officer | 57 | 00-04-30 |
Juan Ye
BRD | Director/Board Member | 53 | 21-11-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 49.45 | +0.20% | 4,659,355 |
24-05-30 | 49.35 | -1.10% | 2,116,792 |
24-05-29 | 49.9 | +2.36% | 2,850,400 |
24-05-28 | 48.75 | -2.11% | 3,189,800 |
24-05-27 | 49.8 | -0.40% | 3,535,573 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.90% | 6.38B | |
+12.28% | 388B | |
+12.61% | 136B | |
+16.62% | 76.27B | |
-12.57% | 65.56B | |
-15.65% | 44.23B | |
-10.36% | 36.96B | |
+6.37% | 35.04B | |
+7.80% | 18.02B | |
+12.30% | 15.57B |
- Stock Market
- Equities
- 2367 Stock